Dan Wallace & Maggie Nixon
Capstan Medical’s Platform is designed to treat mitral and tricuspid valve disease through a catheter while the heart is still beating. Their cutting-edge solution combines advancements in surgical robotics with a catheter-based approach and provides a less invasive alternative to open heart surgery.
The Capstan Platform will enable improved patient outcomes and shorter recovery times. With a dedicated team of heart valve device experts and robotics engineers, the team is fully committed to developing a comprehensive and transformative solution that will positively impact the lives of patients affected by these conditions.
“Heart disease is still the leading cause of death. Capstan treats valve disease so patients can quickly return to their lives.”
Co-Founder and CEO, Capstan
Maggie Nixon
